Plus   Neg

ASML Q3 Profit Down, Bookings Climb; Sees Growth In FY19 - Quick Facts

Dutch semiconductor equipment maker ASML Holding N.V. (ASML) reported Wednesday that its third-quarter net income dropped to 626.8 million euros from last year's 680.4 million euros.

Net income per ordinary share fell to 1.49 euros from 1.60 euros a year ago.

Net sales for the quarter increased to 2.99 billion euros from 2.78 billion euros in the previous year.

Net system sales increased, partly offset by weak net service and field option sales.

Net bookings in the quarter were 5.1 billion euros, significantly higher than last year's 2.20 billion euros. Net bookings of lithography systems grew to 81 units from 67 units last year.

Looking ahead, for the fourth quarter of 2019, ASML expects net sales of around 3.9 billion euros, and a gross margin between 48% and 49%.

ASML President and Chief Executive Officer Peter Wennink said, "Our overall view for 2019 is essentially unchanged as we continue to see 2019 as a growth year."

Further, ASML announced that it has revised its capital return policy to provide for dividend payments on a semi-annual basis. The interim dividend over 2019 will be 1.05 euros per ordinary share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT